# Modulation of Bifidocentric Dysbiosis Through Bifidobacterium Bifidum PRL2010 Supplementation in Caesarian-born Infants

> **NCT05936541** · NA · COMPLETED · sponsor: **Liaquat University of Medical & Health Sciences** · enrollment: 20 (actual)

## Conditions studied

- Disbiosis

## Interventions

- **DIETARY_SUPPLEMENT:** Probiotic Bifidobacterium Bifidum PRL2010
- **OTHER:** Control group

## Key facts

- **NCT ID:** NCT05936541
- **Lead sponsor:** Liaquat University of Medical & Health Sciences
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-05
- **Primary completion:** 2021-05-02
- **Final completion:** 2021-05-25
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2023-07-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05936541

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05936541, "Modulation of Bifidocentric Dysbiosis Through Bifidobacterium Bifidum PRL2010 Supplementation in Caesarian-born Infants". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05936541. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*